Roche has made its case for BTK inhibitor fenebrutinib as a potential new oral therapy for multiple sclerosis, with a phase 2 readout that it says shows significant improvements in disease ...

The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B ...

UNLV men's basketball coach Kevin Kruger is out after four seasons, the school announced Saturday. The Runnin' Rebels' season ended Thursday with a quarterfinal loss to Utah State in the Mountain ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.

As diplomatic tensions continue between Canada and the United States, a travel group says Islanders are rethinking their travel plans, opting for alternative vacation destinations that are either ...

Medicinal Chemistry Research Group and National Drug Discovery and Development Laboratory, HUN-REN Research Centre for Natural Sciences, 2 Magyar tudósok krt, Budapest 1117, Hungary ...